Log In
Print this Print this

Buccolam, midazolam

  Manage Alerts
Collapse Summary General Information
Company Shire plc
DescriptionOral formulaition of midazolam for buccal delivery
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationSeizures
Indication DetailsTreat prolonged, acute, convulsive seizures in patients 3 months to <18 years
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today